NCT02424968
- Conditions
- Acute Myeloid Leukemia, B-Cell Non-Hodgkin Lymphoma, Bone Marrow Diseases, +30 more
- Locations
-
- Stanford University, School of Medicine Stanford, California, United States
Clinical trial condition
Lymphoma, T-Cell
Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.
181 public trials
52 recruiting studies
Lymphoma, T-Cell trial results
NCT01941680
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- CHU Pinteà Pitre/Abymes Pointe-à-Pitre, Guadeloupe
- CHU de Martinique Fort-de-France, Martinique
Completed
A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma
NCT01990534
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +16 more
- Locations
-
- Prague, Czechia
- Brno, Czechia
- Heidelberg, Baden-Wurttemberg, Germany
- Cologne, Germany
NCT00542919
- Conditions
- B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Anaheim, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Garran, Australian Capital Territory, Australia
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gosford, New South Wales, Australia
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Auchenflower, Queensland, Australia
Completed
A Pilot Study of Sorafenib Examining Biomarkers in Refractory or Relapsed T-Cell Lymphoma Patients
NCT01561833
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Yale Cancer Center New Haven, Connecticut, United States
NCT01921387
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +18 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT01902225
- Conditions
- Cutaneous Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT00082888
- Conditions
- Anaplastic Large Cell Lymphoma, Chronic Disease, Disease Attributes, +37 more
- Locations
-
- University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT00992446
- Conditions
- Adult Diffuse Large B-Cell Lymphoma, B-Cell Non-Hodgkin Lymphoma, Follicular Lymphoma, +17 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00426764
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Moore UCSD Cancer Center La Jolla, California, United States
- UCLA Division of Hematology Oncology Los Angeles, California, United States
- University of California, San Francisco San Francisco, California, United States
- Rocky Mountain Cancer Centers-Aurora Aurora, Colorado, United States